PMV Pharmaceuticals, Inc. is developing first-in-class p53 regulators for the treatment of cancer. PMV Pharma combines unique biological understanding with pharmaceutical development focus.

Biotechnology

PMV Pharmaceuticals

PMV Pharmaceuticals' headquarters in Cranbury, NJ, United States

David H. Mack

Fellous Marc

Michael Carulli

Shibu Sleeba

Crystal Zuckerman

Marc Fellous

Tim Smith

Binh Vu

Laura De Leon

Robert Ticktin

Deepika Jalota

Charles Sawyers

Richard A. Heyman

Guillermina Lozano

Laurie Stelzer

Frank Mccormick

Scott Lowe

Karen Vousden

Michael E. Jung

Charles M. Baum

Thomas Shenk

Arnold J. Levine

Kirsten Flowers

Carol Gallagher

The Clinical Development and Operations team at PMV Pharmaceuticals is responsible for designing, implementing, and overseeing clinical trials to develop and validate p53 regulatory therapies for cancer treatment. This team ensures that studies are conducted efficiently, comply with regulatory standards, and translate preclinical findings into clinical success while maintaining rigorous quality assurance.

Clinical Development and Operations

The Leadership Team at PMV Pharmaceuticals is responsible for guiding the strategic direction of the company, overseeing the development of innovative p53 regulators for cancer treatment. This team comprises co-founders and key executives who collaborate to ensure effective drug discovery, regulatory compliance, clinical operations, and financial management, driving the company's vision and operational excellence.

Leadership Team

The Human Resources & Administration team at PMV Pharmaceuticals is responsible for spearheading recruitment, managing employee relations, ensuring legal compliance, and overseeing workplace facilities. The team supports the company's mission by maintaining a productive and compliant work environment to advance the development of pioneering p53 cancer treatments.

Human Resources & Administration

The Research and Development team at PMV Pharmaceuticals is responsible for advancing the discovery and development of novel p53 regulators for cancer treatment. Comprising experts in biological research and translational oncology, the team conducts cutting-edge experiments, analyzes data, and works toward translating scientific findings into viable pharmaceutical therapies.

Research and Development

The Finance Team at PMV Pharmaceuticals oversees the company's financial health and strategies. This includes managing financial planning, reporting, and compliance to ensure the effective allocation of resources for the development of groundbreaking p53 cancer treatments. The team collaborates closely to optimize budgets, forecast financial performance, and support strategic decision-making.

Finance Team

The Clinical Development and Medical Affairs team at PMV Pharmaceuticals leads the design, execution, and analysis of clinical trials to evaluate the efficacy and safety of first-in-class p53 regulators. They also oversee drug safety, pharmacovigilance, and engage with regulatory authorities to ensure compliance and facilitate the advancement of cancer treatments.

Clinical Development and Medical Affairs

PMV Pharmaceuticals

Org chart

Board & advisors

Teams

Clinical Development and Operations

Leadership Team

Human Resources & Administration

Research and Development

Finance Team

Clinical Development and Medical Affairs

Offices

PMV Pharmaceuticals

Org chart

Board & advisors

Teams

Clinical Development and Operations

Leadership Team

Human Resources & Administration

Research and Development

Finance Team

Clinical Development and Medical Affairs

Offices

Related companies